For example, PAX5-JAK2 should be classified under JAK2-FM rather than PAX5-FM since the gene expression signature and the clinical manifestations of PAX5-JAK2-positive ALL are similar to BCR-ABL1-like ALL. This evidence concerns the gene PAX5 and acute lymphoblastic leukemia.